Calcium and magnesium for oxaliplatin-induced neuropathy

Am J Health Syst Pharm. 2014 Jun 15;71(12):987-8. doi: 10.2146/ajhp140026.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Calcium / therapeutic use*
  • Humans
  • Magnesium / therapeutic use*
  • Organoplatinum Compounds / adverse effects*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Peripheral Nervous System Diseases / chemically induced
  • Peripheral Nervous System Diseases / prevention & control*
  • Randomized Controlled Trials as Topic

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin
  • Magnesium
  • Calcium